Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
11/1/2024
Recent Executive Moves
11/1/2024
NMPA Issues Announcement for Applicability of ICH Guideline M12
11/1/2024
NHC Minister Engages in Video Conference with WHO Director-General
(Free)
11/1/2024
Shanghai Unveils Initiative to Boost Local Biopharma's Global Expansio...
11/1/2024
Global Biotech Supply Chain: A Shift Away from China and Opportunities...
11/1/2024
Merck Faces Gardasil Sales Challenges in China, Impact Expected to Con...
11/1/2024
Hengrui Pharma Weighs Hong Kong IPO to Drive Global Expansion
11/1/2024
U.S. Drugmakers Seek Alternatives to Chinese Supply Chains Amid Rising...
10/31/2024
Biostar Pharma Debutx on the Hong Kong Stock Exchange
10/31/2024
CirCode Advances Gene Therapy with HM2002 IND Approval
10/31/2024
AllianThera's IND for IBD Candidate ATB102 Cleared by the USFDA
10/31/2024
CStone Announces MHRA Approval of Sugemalimab for First-Line NSCLC Tre...
10/31/2024
CDE Issues the List of Reference Formulations for GQCE Studies (84th B...
10/30/2024
China Set to Achieve Full Drug and Medical Consumables Traceability by...
10/30/2024
Zai Lab and BMS Move Toward KarXT Filing in China After Positive Phase...
10/30/2024
AstraZeneca China President Under Investigation Amid Broader Scrutiny ...
10/30/2024
Innovent Announces Positive Phase 2 Results for Picankibart in Psorias...
10/30/2024
China's BMI Negotiation Spotlight Record Number of Orphan Drugs
10/30/2024
Eli Lilly's Weight-Loss Drug Mounjaro Set to Debut in Hong Kong
10/29/2024
Innovative Drugs Lead the 2024 Health Insurance Price Negotiations in ...
10/29/2024
Clover Announces Positive Results for RSV Vaccine SCB-1019 vs GSK's AR...
10/29/2024
GSK Acquires CMG1A46 from Chimagen Biosciences to Expand Immunology P...
10/29/2024
Nine Pharma MNCs Grew Their Combined China Revenue at 12.5% CAGR betwe...
10/29/2024
SMEI: Chinese Terminal Drug Market Fell 1.9% in H1/2024 (with Annual M...
10/29/2024
CDE Issues the Common Issues and Technical Requirements for Replicatio...
10/28/2024
China Begins 2024 NRDL Negotiations with Key Focus on Innovation and P...
10/28/2024
China Expands Contract Manufacturing for Biopharmaceuticals in New Pil...
10/28/2024
NiKang Presents Discovery of NKT3964, a FIC, Highly Potent and Selecti...
10/28/2024
Baxter Halts Intravenous Therapy Operations in China Amid Market Chall...
10/28/2024
BeiGene Executive Under Investigation in China Amid Scrutiny of AstraZ...
Page:
34
/
51
Total number of articles:
1510
:
[First]
[<<]
[32]
[33]
[34]
[35]
[36]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit